Bimekizumab Efficacy in Patients With Moderate to Severe Plaque Psoriasis and Hypertension, Elevated Body Mass Index, or Hyperglycemia: Results Through 3 Years of Treatment in 5 Phase 3 3b Trials. J of Skin 2024, 8 (1), s308. https://doi.org/10.25251/skin.8.supp.308.